US 12,459,894 B2
Orally active melanocortin receptor-4 compounds
James Bullington, Hamilton Square, NJ (US); Axel Metzger, Jackson, NJ (US); and John H. Dodd, Spring Mills, PA (US)
Assigned to PALATIN TECHNOLOGIES, INC., Cranbury, NJ (US)
Filed by Palatin Technologies, Inc., Cranbury, NJ (US)
Filed on Mar. 9, 2022, as Appl. No. 17/690,094.
Application 17/690,094 is a continuation of application No. PCT/US2019/051423, filed on Sep. 17, 2019.
Claims priority of provisional application 62/732,680, filed on Sep. 18, 2018.
Prior Publication US 2022/0204450 A1, Jun. 30, 2022
Int. Cl. C07D 211/58 (2006.01); A61K 45/06 (2006.01); A61P 3/04 (2006.01); C07D 401/12 (2006.01)
CPC C07D 211/58 (2013.01) [A61K 45/06 (2013.01); A61P 3/04 (2018.01); C07D 401/12 (2013.01)] 7 Claims
 
1. A compound of formula III:

OG Complex Work Unit Chemistry
or an enantiomer, stereoisomer or diastereomer thereof, or a pharmaceutically acceptable salt thereof.